CLINICAL_TRIALS
trial_result
· 2015-09-29
Clinical Trial Update: GP Extended Action Triptorelin [Phase 4]
Summary
The Phase 4 trial of GP Extended Action Triptorelin for prostate cancer was terminated, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Prostate Cancer | Phase 4 | Status: TERMINATED | Results posted: 2015-09-29